Literature DB >> 7160537

Selective effects of myo-inositol administration on sciatic and tibial motor nerve conduction parameters in the streptozocin-diabetic rat.

D A Greene, R A Lewis, S A Lattimer, M J Brown.   

Abstract

Time-dependent effects of experimental diabetes and dietary myo-inositol supplementation on motor nerve conduction velocity (MNCV) were assessed in two populations of motor nerve fibers in the rat hind limb. These two populations of large myelinated motor fibers, which innervate the musculature of the calf and the foot, were differentially affected by growth, experimental diabetes, and dietary myo-inositol. Dietary myo-inositol supplementation ameliorated the diabetes-induced MNCV impairment in both nerve fiber populations but with different time courses. These observations suggest metabolic or physiologic heterogeneity among populations of large myelinated motor fibers which may partially explain published discrepancies regarding the efficacy of dietary myo-inositol supplementation in improving slowed MNCV in the streptozocin-diabetic rat.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7160537     DOI: 10.2337/diab.31.7.573

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat.

Authors:  N E Cameron; M B Leonard; I S Ross; P H Whiting
Journal:  Diabetologia       Date:  1986-03       Impact factor: 10.122

2.  Comparison of the effects of aminoguanidine and L-carnitine treatments on somatosensorial evoked potentials in alloxan-diabetic rats.

Authors:  O Yildiz; M Ozata; A Ozkardeş; G Deniz; M Yildirimkaya; A Corakçi; M Yardim; M A Gündoğan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

3.  Free inositol, sorbitol and fructose levels in sciatic nerve.

Authors:  W R Sherman; P J Dyck
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

4.  Randomized double-blind placebo-controlled trial to evaluate the effect of the ACTH4-9 analogue ORG 2766 in IDDM patients with neuropathy.

Authors:  B Bravenboer; P H Hendrikse; P L Oey; A C van Huffelen; C Groenhout; W H Gispen; D W Erkelens
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

5.  Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.

Authors:  J H Mayer; D R Tomlinson
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

6.  Relationship between retinal ischemia and cardiovascular autonomic damage in diabetes.

Authors:  A Giardullo; L Ricordi; M Rossi; G Marti; G Vandelli; P Fratino; L Bernardi
Journal:  Acta Diabetol Lat       Date:  1989 Jul-Sep

7.  Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.

Authors:  K R Gillon; J N Hawthorne; D R Tomlinson
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

8.  Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve. Competitive inhibition by glucose and lack of an insulin effect.

Authors:  D A Greene; S A Lattimer
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

9.  Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.

Authors:  P H Whiting; I S Ross
Journal:  Br J Exp Pathol       Date:  1988-10

10.  Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats.

Authors:  R Kikkawa; I Hatanaka; H Yasuda; N Kobayashi; Y Shigeta; H Terashima; T Morimura; M Tsuboshima
Journal:  Diabetologia       Date:  1983-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.